IL298678A - Modified semaphorin 3a, compositions comprising the same and uses thereof - Google Patents
Modified semaphorin 3a, compositions comprising the same and uses thereofInfo
- Publication number
- IL298678A IL298678A IL298678A IL29867822A IL298678A IL 298678 A IL298678 A IL 298678A IL 298678 A IL298678 A IL 298678A IL 29867822 A IL29867822 A IL 29867822A IL 298678 A IL298678 A IL 298678A
- Authority
- IL
- Israel
- Prior art keywords
- modified
- sema3a
- semaphorin
- polypeptide
- cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063034476P | 2020-06-04 | 2020-06-04 | |
| PCT/IL2021/050660 WO2021245670A1 (en) | 2020-06-04 | 2021-06-03 | Modified semaphorin 3a, compositions comprising the same and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL298678A true IL298678A (en) | 2023-01-01 |
Family
ID=78830160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL298678A IL298678A (en) | 2020-06-04 | 2021-06-03 | Modified semaphorin 3a, compositions comprising the same and uses thereof |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230272020A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4161659A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023532415A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115916351A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021284697A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3185618A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL298678A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021245670A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115947817B (zh) * | 2023-02-22 | 2024-07-02 | 甘肃中肽生物科技有限公司 | 一种肿瘤相关多肽及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5288931A (en) * | 1991-12-06 | 1994-02-22 | Genentech, Inc. | Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation |
| GB9912350D0 (en) * | 1999-05-26 | 1999-07-28 | European Molecular Biology Lab Embl | Modified cytokine |
| FI117667B (fi) * | 2001-07-05 | 2007-01-15 | Univ Zuerich | Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä |
| EP2497498A4 (en) * | 2009-11-05 | 2013-04-17 | Univ Osaka | THERAPEUTIC ACTIVE FOR AUTOIMMUNE DISEASES OR ALLERGIES AND METHOD FOR SCREENING AFTER THE THERAPEUTIC ACTIVE SUBSTANCE |
| WO2012106615A1 (en) * | 2011-02-03 | 2012-08-09 | Xoma Technology Ltd. | Methods and materials for enhancing functional protein expression in bacteria |
| WO2014199364A1 (en) * | 2013-06-13 | 2014-12-18 | Bnai Zion Medical Center | Semaphorin 3a for treatment and prognosis of systemic lupus erythematosus |
| AU2015311563B2 (en) * | 2014-09-05 | 2019-11-28 | Rsem, Limited Partnership | Compositions and methods for treating and preventing inflammation |
| EP3262064A1 (en) * | 2015-02-23 | 2018-01-03 | Seagull Therapeutics SAS | Non-natural semaphorins 3 and their medical use |
-
2021
- 2021-06-03 JP JP2022574527A patent/JP2023532415A/ja active Pending
- 2021-06-03 US US17/928,685 patent/US20230272020A1/en active Pending
- 2021-06-03 WO PCT/IL2021/050660 patent/WO2021245670A1/en not_active Ceased
- 2021-06-03 IL IL298678A patent/IL298678A/en unknown
- 2021-06-03 AU AU2021284697A patent/AU2021284697A1/en not_active Abandoned
- 2021-06-03 CA CA3185618A patent/CA3185618A1/en active Pending
- 2021-06-03 EP EP21817238.5A patent/EP4161659A4/en active Pending
- 2021-06-03 CN CN202180040643.7A patent/CN115916351A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4161659A4 (en) | 2024-03-06 |
| WO2021245670A1 (en) | 2021-12-09 |
| EP4161659A1 (en) | 2023-04-12 |
| CN115916351A (zh) | 2023-04-04 |
| US20230272020A1 (en) | 2023-08-31 |
| CA3185618A1 (en) | 2021-12-09 |
| JP2023532415A (ja) | 2023-07-28 |
| AU2021284697A1 (en) | 2023-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102302392B1 (ko) | 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물 | |
| CN106659757B (zh) | 白介素2的超级激动剂、部分激动剂和拮抗剂 | |
| CN111615396A (zh) | 白介素-2的部分激动剂 | |
| CN110357953B (zh) | 识别人巨细胞病毒pp65抗原的TCR | |
| WO2001019999A1 (en) | A GENE ENCODING A NOVEL THREONYL-tRNA SYNTHETASE, ITS USES AND THE PREPARING METHODS | |
| US20250270272A1 (en) | Methods of treating multiple sclerosis using autologous t cells | |
| EP4310188A1 (en) | Gene coding for chimeric receptor for anti-acetylcholine receptor autoantibody | |
| EP1019502A2 (en) | Human orphan receptor ntr-1 | |
| EP4010006B1 (en) | Hla-dr/cii peptide complexes for treating arthritis | |
| US20190000921A1 (en) | Semaphorin 3a for treatment and prognosis of systemic lupus erythematosus | |
| US20230272020A1 (en) | Modified semaphorin 3a, compositions comprising the same and uses thereof | |
| Daub et al. | Expression of members of the S100 Ca2+-binding protein family in guinea-pig smooth muscle | |
| KR20240128579A (ko) | Cd38 또는 이의 단편을 포함하는 자가면역질환 치료용 조성물 | |
| CN115141268B (zh) | 抗炎cd209多肽片段及其抗脂肪性肝病炎症的应用 | |
| US9943567B2 (en) | Method for treating arthritis using IK factor or nucleic acid encoding IK factor | |
| CN120019146A (zh) | 通用t细胞和组合物及它们的使用方法 | |
| AU6176696A (en) | Interleukin-1 receptor-associated protein kinase and assays | |
| EP2032601B1 (en) | Peptides regulating the surface expression of the t cell receptor | |
| CN112538108B (zh) | 高亲和pvr突变体 | |
| WO2001038371A1 (en) | A NOVEL POLYPEPTIDE-HUMAN GLUTAMATE tRNA SYNTHETASE 58 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE | |
| EP4667486A1 (en) | Composition comprising cd38 or fragment thereof for treating autoimmune diseases | |
| WO2008118100A1 (en) | Method of enhancing migration of neural precursor cells | |
| US6908765B1 (en) | Polypeptide—human SR splicing factor 52 and a polynucleotide encoding the same | |
| HK40103877A (en) | Gene coding for chimeric receptor for anti-acetylcholine receptor autoantibody | |
| US20260041789A1 (en) | Gene therapy DNA vector based on gene therapy DNA vector GDTT1.8NAS12 carrying the therapeutic gene selected from the group of DDC, IL10, IL13, IFNB1, TNFRSF4, TNFSF10, BCL2, HGF, and IL-2 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain JM110-NAS/GDTT1.8NAS12-DDC, or Escherichia coli strain JM110-NAS/GDTT1.8NAS12-IL10, or Escherichia coli strain JM110-NAS/GDTT1.8NAS12-IL13, or Escherichia coli strain JM110-NAS/GDTT1. |